問題詳情

25 下列有關白血球群落刺激因子(colony-stimulating factor, CSF)之使用,何者正確?
(A) 劑量係依白血球下降程度而調整
(B) 於化學治療療程開始前即應給予 CSF
(C) CSF 停止使用後,嗜中性白血球數目可能會下降約 50%
(D) 所有 febrile neutropenia 的病人皆應給予 CSF 治療

參考答案

答案:C
難度:適中0.454545
統計:A(4),B(3),C(10),D(1),E(0)

用户評論

【用戶】Camille Hsu

【年級】高二下

【評論內容】(A)G-CSF應給之劑量係依病人體重而★。★★...

【用戶】野原廣志

【年級】高三下

【評論內容】(A)看是使用哪種(***注意單位)     filgrastim(G-CSF): 5mcg/kg     peglyated G-CSF: 6mg/cycle    sargramostim(GM-CSF): 250mcg/mm2(B)給法     filgrastim(G-CSF): 在化療前後24hr停藥     peglyated G-CSF: 在化療前14天道化療後24hr停藥(D)看情況-CSF should not be used routinely in patients with neutropenia who are afebrile (ASCO Strong recommendation, High-quality evidence)-consider CSF for patients with fever and neutropenia at high risk for infection-associated complications or who have prognostic factors predictive of poor clinical outcomes, including (ASCO Strong recommendation, High-q...